@article{93ae46b0016b42ce9319f8144d20dd34,
title = "Going with the Flow: The Promise of Plasma-Only Circulating Tumor DNA Assays",
abstract = "Circulating tumor DNA (ctDNA) has emerged as a non-invasive diagnostic and prognostic tool for colorectal cancer (CRC). Here, we discuss studies that evaluate the ability of plasma-only ctDNA assays to detect minimal residual disease (MRD) and the potential benefit of integration of methylation into ctDNA assays.",
author = "Scott Kopetz and Alisha Bent",
note = "Funding Information: Acknowledgment: S. Kopetz is supported by the National Institutes of Health (P50CA221707, P30CA16672, R01CA218230, and R01CA184843). Publisher Copyright: {\textcopyright} 2021 American Association for Cancer Research.",
year = "2021",
month = oct,
day = "15",
doi = "10.1158/1078-0432.CCR-21-2181",
language = "English (US)",
volume = "27",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "20",
}